|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 38/14 | |
| A61K 47/26 | |||
| A61K 9/08 | |||
| A61P 31/04 |
| (11) | Number of the document | 3542812 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19174849.0 |
| Date of filing the European patent application | 2015-11-06 | |
| (97) | Date of publication of the European application | 2019-09-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-01-13 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462076400 P | 2014-11-06 | US | |
| 201562168749 P | 2015-05-30 | US |
| (72) |
Jasprica, Ivona, HR
Keser, Sabina, HR
Pindric, Katarina, HR
|
| (73) |
Xellia Pharmaceuticals ApS,
Dalslandsgade 11, 2300 Copenhagen S,
DK
|
| (54) | GLYCOPEPTIDE COMPOSITIONS |
| GLYCOPEPTIDE COMPOSITIONS |